We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6881:HKEXChina Galaxy Securities Co., Ltd. Class H Analysis

Data as of 2026-03-14 - not real-time

CN¥58.53

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Zhejiang Lante Optics is trading well above its 20‑day SMA of ~53.75 and comfortably above the 50‑day SMA of ~46.97, while still under the 200‑day SMA of ~33.83, indicating a strong bullish bias. The RSI of 60.5 and a bullish MACD histogram (+0.68) reinforce upward momentum, with the price holding above the identified support at 46.2 and still below the near‑term resistance of 65.9. Volume is on an increasing trend, and the market sentiment index reads “Greed” at 72.88, suggesting appetite for risk. However, the stock’s valuation appears stretched: a trailing PE of 76x dwarfs the industry average of 33.7x, and the price‑to‑book ratio exceeds 11. Despite this, the company posted an exceptional revenue growth of 95.7% YoY, with robust operating margins (~31%) and a modest debt‑to‑equity profile, supporting the sustainability of its 0.34% dividend. The 30‑day volatility is high at 84%, yet beta remains low (0.36), indicating limited systematic risk. In summary, the stock shows strong short‑term technical upside, but valuation concerns and elevated volatility temper confidence for longer horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA, RSI, MACD)
  • Strong support at 46.2 and increasing volume
  • High short‑term volatility may cause price swings

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Outstanding revenue growth but valuation remains stretched
  • Solid operating margins and low debt levels
  • Potential price correction toward fair value

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Secular demand for optics in AR/VR, automotive and semiconductor sectors
  • Sustained earnings growth and dividend sustainability
  • Long‑run upside as market re‑rates growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth95.70%
Profit Margin25.28%
P/E Ratio76.0
ROE20.15%
Debt/Equity3.26
P/B Ratio11.7
Industry P/E33.7

Technical Analysis

TrendBullish
RSI60.5
SupportCN¥46.20
ResistanceCN¥65.90
MA 20CN¥53.75
MA 50CN¥46.97
MA 200CN¥33.83
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

GradeOvervalued
TypeGrowth
Dividend Yield0.34%

Risk Assessment

Beta0.36
Volatility84.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.